Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Betting on India’s travel boom? Motilal Oswal sees TBO Tek and Ixigo as key beneficiaries
The industry has evolved significantly over the past two decades—from a fragmented, offline agent-driven market to a digitally enabled ecosystem led by online travel platforms.

Motilal Oswal prefers Amber and Dixon, stays cautious on Bata
Siddhartha Khemka, Head of Research, Wealth Management, Motilal Oswal Financial Services, remains cautious on Bata despite the appointment of a new CEO, citing market share losses and valuation concerns. He is positive on Amber Enterprises due to its Oppo manufacturing partnership and expects mobile operations to contribute meaningfully from FY28-FY29. He also sees upside in Dixon Technologies driven by the proposed Vivo joint venture. For Reliance Industries, easing inflation, strength in oil-to-chemicals and updates from the AGM remain key factors for investors. Disclaimer: The views and tips expressed by investment experts on CNBCTV18.com are their own, not of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

Nykaa Shares in Focus: Motilal Oswal Cautious on Valuations; Maintains Neutral — Check Target Price
Motilal Oswal believes that beauty remains Nykaa's key value driver, benefiting from premiumisation, rising online penetration, omnichannel expansion and scaling owned brands such as Dot & Key.
Natural gas prices rebound as inventories tighten, LNG exports rise: Motilal Oswal
Natural gas prices are climbing back up. This recovery is driven by lower stored gas, increased power sector use, and more US liquefied natural gas exports. Future growth is expected as new export facilities come online. Data centers are also becoming a new source of demand. The market is seeing a significant shift.
Motilal Oswal bullish on online travel portals
Motilal Oswal Financial Services has initiated coverage on online travel platforms Le Travenues Technology (Ixigo) and Yatra Online with a buy rating, while reiterating a buy on TBO Tek citing a structural uptrend in domestic travel and potential earnings growth as key drivers.

Motilal Oswal sees up to 30% upside in these three travel stocks; Here's why
The brokerage reaffirmed its 'Buy' recommendation on TBO Tek, while initiating coverage on Ixigo and Yatra Online with positive ratings.
Stable crude, strong metal demand and El Nino plays drive opportunities: Motilal Oswal's Khemka
Siddhartha Khemka, Head of Research-Wealth Management at Motilal Oswal Financial Services, says easing geopolitical tensions could keep crude oil prices stable, supporting oil marketing companies. He remains positive on GNG Electronics due to strong growth prospects in refurbished electronics and prefers Hindalco among aluminium stocks, citing a multi-year demand cycle. Khemka also sees long-term value in Manappuram Finance and believes Voltas and Varun Beverages could benefit from a potential El Niño-led heatwave.

Privi Speciality in Focus: Motilal Oswal Remains Bullish on Strong Growth Story — Check Target Price
The upcoming mergers with Privi Fine Science, Privi BiotechnologiesL and PRIGIV JV with Givaudaare expected to expand Privi's specialty aroma portfolio, which is expected to drive revenue growth, enhance earnings.

ICICI Prudential Mutual Fund raises stake in Travel Food Services, shares rise
ICICI Prudential Mutual Fund has announced the acquisition of an additional stake in Travel Food Services, increasing its total shareholding in the company to above 5%.

ICICI Lombard: AI Integration Lifts Growth Outlook — Buy, Sell or Hold? Read Motilal Oswal's Analysis
Leadership in motor insurance, accelerating momentum in retail health, expanding distribution capabilities, growing AI integration and a strong balance sheet remains ICICI Lombard's key growth drivers.

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.